Miravirsen dosing in chronic hepatitis C patients results in decreased microRNA-122 levels without affecting other microRNAs in plasma

LO7 : A single subcutaneous dose of 2mg/kg or 4mg/kg of RG-101, a GalNAc-conjugated oligonucleotide with antagonist activity against MIR-122, results in significant viral load reductions in chronic hepatitis C patients

(2015) M. Van Der Ree et al.   JOURNAL OF HEPATOLOGY

Dissecting the Roles of the 5′ Exoribonucleases Xrn1 and Xrn2 in Restricting Hepatitis C Virus Replication

(2015) You Li et al.   JOURNAL OF VIROLOGY

Interaction of Host Cell microRNAs with the HCV RNA Genome during Infection of Liver Cells

(2015) Cecilia Sedano et al.   SEMINARS IN LIVER DISEASE

In VitroAntiviral Activity and Preclinical and Clinical Resistance Profile of Miravirsen, a Novel Anti-Hepatitis C Virus Therapeutic Targeting the Human Factor miR-122

(2014) Søren Ottosen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients

(2014) Meike H. van der Ree et al.   ANTIVIRAL RESEARCH

MicroRNAs: role and therapeutic targets in viral hepatitis

(2014) Meike H van der Ree et al.   ANTIVIRAL THERAPY

Hepatitis C Virus Subverts Liver-Specific miR-122 to Protect the Viral Genome from Exoribonuclease Xrn2

(2014) Cecilia D. Sedano et al.   Cell Host & Microbe

Circulating microRNAs as markers of liver inflammation, fibrosis and cancer

(2014) Christoph Roderburg et al.   JOURNAL OF HEPATOLOGY

The role of microRNAs in hepatitis C virus RNA replication

(2013) K. Dominik Conrad et al.   ARCHIVES OF VIROLOGY

Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

(2013) Adriaan J. van der Meer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Epidemiology and natural history of HCV infection

(2013) Behzad Hajarizadeh et al.   Nature Reviews Gastroenterology & Hepatology

Treatment of HCV Infection by Targeting MicroRNA

(2013) Harry L.A. Janssen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Miravirsen (SPC3649) can inhibit the biogenesis of miR-122

(2013) Luca F. R. Gebert et al.   NUCLEIC ACIDS RESEARCH

Let-7b is a novel regulator of hepatitis C virus replication

(2012) Ju-Chien Cheng et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Circulating MicroRNAs

(2012) Esther E. Creemers et al.   CIRCULATION RESEARCH

Transient Activation of the PI3K-AKT Pathway by Hepatitis C Virus to Enhance Viral Entry

(2012) Zhe Liu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122

(2012) A. J. van der Meer et al.   JOURNAL OF VIRAL HEPATITIS

Serum miR-122 as a Biomarker of Necroinflammation in Patients With Chronic Hepatitis C Virus Infection

(2011) Verena Bihrer et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Alterations in microRNA expression profile in HCV-infected hepatoma cells: Involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway

(2011) Hisashi Ishida et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C

(2011) Lisa I. Backus et al.   Clinical Gastroenterology and Hepatology

MicroRNAs in body fluids—the mix of hormones and biomarkers

(2011) Maria Angelica Cortez et al.   Nature Reviews Clinical Oncology

Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease

(2011) Silvia Cermelli et al.   PLoS One

Masking the 5' terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex

(2011) E. S. Machlin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Circulating microRNAs: Association with disease and potential use as biomarkers

(2010) Glen Reid et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis

(2010) Ana-Carolina Cardoso et al.   JOURNAL OF HEPATOLOGY

Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans

(2010) Rebecca T Marquez et al.   LABORATORY INVESTIGATION

Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C

(2010) Kazutoyo Morita et al.   LIVER INTERNATIONAL

MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib

(2009) Shoumei Bai et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

(2009) C Coulouarn et al.   ONCOGENE

Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection

(2009) R. E. Lanford et al.   SCIENCE

Regulation of the hepatitis C virus genome replication by miR-199a

(2008) Yoshiki Murakami et al.   JOURNAL OF HEPATOLOGY

Analyzing real-time PCR data by the comparative CT method

(2008) Thomas D Schmittgen et al.   Nature Protocols

Circulating microRNAs as stable blood-based markers for cancer detection

(2008) P. S. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA